Evidence map›Paper›PMID 28878310›Full record

ArticleScientific reports2017

Large-scale production of recombinant human lactoferrin from high-expression, marker-free transgenic cloned cows.

Ming Wang, Zhaolin Sun, Tian Yu, Fangrong Ding, Ling Li, Xi Wang, Mingbo Fu, Haiping Wang, Jinming Huang, Ning Li and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 61 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Outlook on genome editing application to cattle.Journal of veterinary science · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Use of Genome Editing Techniques to Produce Transgenic Farm Animals.Advances in experimental medicine and biology · 2022
    Review
  13. Article
  14. Article
  15. Article
  16. Strategy to Establish Embryo-Derived Pluripotent Stem Cells in Cattle.International journal of molecular sciences · 2021
    Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Ming WangState Key Laboratory for Agrobiotechnology, College of Biological Sciences, China Agricultural University, Beijing, China.
Zhaolin SunState Key Laboratory for Agrobiotechnology, College of Biological Sciences, China Agricultural University, Beijing, China.
Tian YuKejienuo Biotechnology Company, Wuxi, China.
Fangrong DingState Key Laboratory for Agrobiotechnology, College of Biological Sciences, China Agricultural University, Beijing, China.
Ling LiState Key Laboratory for Agrobiotechnology, College of Biological Sciences, China Agricultural University, Beijing, China.
Xi WangKejienuo Biotechnology Company, Wuxi, China.
Mingbo FuKejienuo Biotechnology Company, Wuxi, China.
Haiping WangState Key Laboratory for Agrobiotechnology, College of Biological Sciences, China Agricultural University, Beijing, China.
Jinming HuangDairy cattle Research Center, Academy of Agricultural Sciences, Shandong, China.
Ning LiState Key Laboratory for Agrobiotechnology, College of Biological Sciences, China Agricultural University, Beijing, China. ninglcau@cau.edu.cn.
Yunping DaiState Key Laboratory for Agrobiotechnology, College of Biological Sciences, China Agricultural University, Beijing, China. daiyunping@sina.com.
China Agricultural University · CNShandong Academy of Agricultural Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human lactoferrin (hLF) is a valuable protein for pharmaceutical products and functional foods, and worldwide demand for this protein has steadily increased. However, large-scale recombinant human lactoferrin (rhLF) production using current animal bioreactor techniques is limited by the low expression of foreign proteins, the use of antibiotic resistance genes and the down-regulation of endogenous milk proteins. Here, we generated a herd of marker-free, hLF bacterial artificial chromosome (BAC) transgenic cloned cows, as confirmed by Polymerase chain reaction, Southern blot and Western blot analyses. These transgenic cloned cows produced rhLF in milk at concentrations of 4.5-13.6 g/L. Moreover, the total protein content of the milk was increased. Over two hundred transgenic cloned cows were propagated by multiple ovulation and embryo transfer (MOET). A total of 400-450 g of rhLF protein, which shows similar enzymatic activity to natural hLF in iron binding and release, can be purified on a large scale from >100 L of milk per day. Our results suggested that transgenic bovine mammary bioreactors have the potential for large-scale protein production.

Indexed as

Gene ExpressionAnimalsAnimals, Genetically ModifiedBioreactorsCattleGene OrderGenetic VectorsHumansIronLactoferrinMilkMilk ProteinsProtein BindingRecombinant ProteinsTransfectionIronLactoferrinLTF protein, humanMilk ProteinsRecombinant Proteins

Identifiers

PMID28878310
PMCPMC5587717
OpenAlexW2752770141

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.